Приоритетные методы оценки прогноза и тяжести течения цирроза печени. Современные подходы к определению тактики лечения

Приоритетные методы оценки прогноза и тяжести течения цирроза печени. Современные подходы к определению тактики лечения

Автор: Назыров Ф.Г., Девятов А.В., Бабаджанов А.Х.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Рубрика: Обзоры литературы

Статья в выпуске: 3 т.8, 2013 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140188229

IDR: 140188229

Список литературы Приоритетные методы оценки прогноза и тяжести течения цирроза печени. Современные подходы к определению тактики лечения

  • Андрейцева О.И., Гуляев В.А., Журавель С.В., Джаграев К.Р. Принципы отбора больных для трансплантации печени//Клинич.перспективы гастроэнтерологии, гепатологии. -2002. -№ 4. -С. 12-19.
  • Журавель С.В., Андрейцева О.И., Новрузбеков М.С., Чжао А.В. Прогнозирование и трансплантация печени при острой печеночной недостаточности//Consilium medicum. Хирургия. 2005. -Т. 7. -Приложение № 1. -С. 80-82.
  • Ивашкин В.Т. Болезни печени и желчевыводящих путей: Руководство для врачей. -2-е изд. -М.: Изд. дом «М-Вести», 2005. -536 с.
  • Ивашкин В.Т., Павлов Ч.С. Опухоли печени, предраковые заболевания и состояния. Гепатоцеллюлярная карцинома//Рациональная фармакотерапия пищеварения/Под ред. В.Т. Ивашкина. -М.: Литтерра, 2003. -С. 459-464.
  • Павлов Ч.С., Глушенков Д.В., Ивашкин В.Т. Современные возможности эластометрии, Фибро-и АктиТеста в диагностике фиброза печени//Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2008, том XVIII., № 4, -С. 43-52.
  • Павлов Ч.С., Золоторевский В.Б., Ивашкин В.Т. и соавт. Возможность обратимости цирроза печени (клинические и патогенетические предпосылки).//Рос. журн. гастроэнтерол., гепатол., колопроктол. -2006. -Т. 16, № 1. -С. 20-29.
  • Пирогова И.Ю., Пышкин С.А. Диагностика фиброза печени: инвазивные и неизвазивные методы//Сибирский медицинский журнал (Иркутск), 2011, № 3. -С. 10-15.
  • Bensamoun S.F., Wang L., Robert L., et al. Measurement of liver stiffness with two imaging techniques: magnetic resonance elastography and ultrasound elastography. J Magn Reson Imaging. 2008; 28: 1287-1292.
  • Brown R.S., Lake J.R. The survival impact of liver transplantationi the MELD era, and the future for organ allocation and distribution//Am. J. Transplant. Vol. 5. 2005. Р. 203-205.
  • Butt A.K., Khan A.A., Alam A., Shah S.W.H., Shafqat F., Naqvi A.B.: Predicting hospital mortality in cirrhotic patients: Comparison of Child-Pugh and Acute Physiology, Age and Chronic Health Evaluation (APACHE III) scoring systems. Am J Gastroenterol 1998, 93: 2469-2475.
  • Castera L., Forns X., Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography//J.Hepatol. -2008. -Vol. 48, N 5. -P. 835-847.
  • Chatzicostas C., Roussomoustakaki M., Notas G. et al. A comparison of Child-Pugh, APACHE II and APACHE III scoring systems in predicting hospital mortality of patients with liver cirrhosis//BMC Gastroenterology. 2003, 3: 7.
  • Child C.G., Turcotte J.G.: Surgery and portal hypertension. In The liver and portal hypertension. Edited by Child CG. Philadelphia, Saunders; 1964: 50-64.
  • Coco B., Oliveri F., Maina A.M., et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007; 14: 360-369.
  • Conn H.O.: Transjugular intrahepatic shunts: the state of the art. Hepatology 1993, 17: 148-158.
  • Desmet V.J. Cirrhosis reversal: a duel between dogma and myth//J. Hepatol. -2004. -Vol. 40. -P. 860-867.
  • Farnsworth N., Fagan S.P., Berger D.H., Awad S.S. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.Am J Surg. 2004 Nov; 188(5): 580-3.
  • Ferard G., Piton A., Messous D., Imbert-Bismut F., Frairi A., Poynard T., Lessinger J.M. Intermethod calibration of alanine aminotransferase (ALT) and gammaglutamyltransferase (GGT) results: application to FibroTest and ActiTest scores.//Clin. Chem. Lab. Med. -2006. -Vol. 44. -Р. 400-406.
  • Fernandez-Esparrach G., Sanchez-Fueyo A., Ginès P., et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001; 34: 46-52.
  • Ferro D., Saliola M., Quintarelli C., Alessandri C., Basili S., Violi F.: 1-Year survey of patients with advanced liver cirrhosis: prognostic value of clinical and laboratory indexes identified by the Cox regression model. Scand J Gastroenterol 1992, 27: 852-856.
  • Fisher R.A., Heuman D.M., Harper A.M. et al., "Region 11 MELD Na exception prospective study,” Annals of Hepatology, vol. 11, no. 1, pp. 62-67, 2012.
  • Fleck A., Raines G., Hawker F., et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985; 1: 781-784
  • Foucher J., Chanteloup E., Vergniol J., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006; 55: 403-408.
  • Guan R., Foong Lui H. Treatment of Hepatitis B in Decompensated Liver Cirrhosis//International Journal of Hepatology. Volume 2011 (2011), Article ID 918017, 11 pages.
  • Henriksen J.H., Parving H.H., Christiansen L., et al. Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig: relation to findings in patients with cirrhosis of the liver. Scand J Clin Lab Invest 1981; 41: 289-299.
  • Holt A.W., Bury L.K., Bersten A.D., Skowronski G.A., Vedig A.E.: Prospective evaluation of residents and nurses as severity score data collectors. Crit Care Med 1992, 20: 1688-1691.
  • Hsu C.Y., Lin H.C., Huang Y.H. et al. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensate hepatitis//Digestive and Liver Disease, vol. 42, no. 2, pp. 137-142, 2010.
  • Huo T.I., Lin H.C., Wu J.C., Lee F.Y., Hou M.C., Lee P.C., Chang F.Y., Lee S.D. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl. 2006 Jan; 12(1): 65-71.
  • Ishak K., Baptista A., Bianchi L. et al. Histological grading and staging of chronic hepatitis//J. Hepatol. -1995. -Vol. 22. -P. 696-699.
  • Jung G.E., Encke J., Schmidt J., Rahmel A. (February 2008). "Model for endstage liver disease. New basis of allocation for liver transplantations” (in German). Chirurg 79 (2): 157-63.
  • Kamath P.S., Kim W.R.; Advanced Liver Disease Study Group. The model for endstage liver disease (MELD). Hepatology. 2007 Mar; 45(3): 797-805.
  • Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., D'Amico G., Dickson E.R., Kim W.R.: A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33: 464-470.
  • Kim K.M., Choi W.-B., Park S.H., et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol. 2007; 42: 382-388.
  • Kim W., Biggins S., Kremers W. et al. Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List//NEJM. -2008. -Vol. 359, N 10. -P. 1018-1026.
  • Leise M.D., Kim W.R., Kremers W.K., Larson J.J., Benson J.T., Therneau T.M. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011 Jun; 140(7): 1952-60.
  • LeMoine O., Adler M., Bourgeois N., Delhayne M., Deviere J., Gelin M., Vandermeeren A., Van Gossum A., Vereerstraeten P.: Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy. Gut 1992, 33: 1381-1385.
  • Liaw Y.F., Chang T.T., Wu S.S. et al. Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in patients with HBe-Ag(+) and (-) chronic hepatitis B: results from studies ETV-022, -027 and -901//Hepatology. -2008. -Vol. 48 (suppl. 1). -P. 706A (abstract 894).
  • Luca A., Angermayr B., Bertolini G. et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis//Liver Transplantation, vol. 13, no. 8, pp. 1174-1180, 2007.
  • Luo J.W., Shao J.H., Bai J., Cui L.G., Wang J.R. Using non-invasive transient elastography for the assessment of hepatic fibrosis.//Zhonghua Gan Bing Za Zhi. -2006. -Vol. 14, N 5. -P. 395-397.
  • Malinchoc M., Kamath P.S., Gordon F.D., et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871.
  • McDiarmid S.V., Anand R., Lindblad A.S. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation. 2002; 74(2) 173-81.
  • Merchante N., Rivero-Juárez A., Téllez F., et al. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Hepatology 56(1): 228-238. July 2012.
  • Mochida S., Takaguchi K., Yokosuka O. et al. Long term efficacy, safety and resistance analyses of entecavir treatment in Japanese nucleoside-naive patients with chronic hepatitis B//J. Hepatol. -2008. -Vol. 48 (suppl. 2). -P. 262.
  • Moseley R.H. Sepsis and cholestasis. Clin Liver Dis 2004; 8: 83-94.
  • Myers R.P., Ratziu V., Charlotte F., Imbert-Bismut F., Poynard T. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.//Am J Gastroenterol. -2002. -Vol. 97. -P. 2419-2425.
  • Oellerich M., Burdelski M., Lautz H.U., et al. Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation 1991; 51: 801-806.
  • Olthoff K.M., Brown R.S., Delmonico F.L., et al. Summary report of a national conference: Evolving concepts in liver transplantation in the MELD and PELD era//Liver Transpl. Vol. 10. 2004. A6-A22.
  • Paradis V., Mathurin P., Ratziu V., Poynard T., Bedossa P. Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix.//Hepatology. -1996. -Vol. 23: 1232-1238.
  • Plessier A., Denninger M.H., Consigny Y., et al. Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int 2003; 23: 440-448.
  • Poison J., Lee W.M. AASLD Position Paper. The Management of Acute Liver Failure. Hepatology. Vol. 41, No. 5. 2005. -P. 117-1197.
  • Polderman K.H., Joma E.M., Girbes A.R.: Inter-observer variability in APACHE II scoring: effect of strict guidelines and training. Intens Care Med 2001, 27: 1465-1369.
  • Poynard T., McHutchison J., Manns M., Trepo C., Lindsay K., Goodman Z., Ling M.H., Albrecht J. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C//Gastroenterology. 2002 May; 122(5): 1303-13.
  • Poynard T., Imbert-Bismut F., Ratziu V., et al. Biochemical markers of liver fibrosis in patients infected by Hepatitis C Virus: Longitudinal validation in a randomized trial//J.Viral Hepatitis. -2002. -Vol. 9. -P. 128-133.
  • Pugh R.N.H., Murray-Lyon Im., Dawson J.L. et al. Transection of the esophagus in bleeding esophageal varices. Br J Surg 1973; 60: 648-52.
  • Schmidt L.E., Larsen F.S. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007 Mar; 45(3): 789-96.
  • Sen S., Williams R., Jalan R. The pathofhysiological basis of acute-on-chronic Liver failure. Liver 2002; 22 (Suppl. 2): 5-13.
  • Shiffman M.L. Natural history and risk factor for progression of hepatitis C virus disease and development of hepatocellularcancer before liver transplantation//Liver Transpl. -2003. -Vol. 9. -Р.P14-S20.
  • Toledo C., Salmeron J.M., Rimola A., Navasa M., Arroyo V., Llach J., Gines A., Gines P., Rodes J.: Spontaneous bacterial peritonitis cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993, 17: 251-257.
  • Wiesner R., Edwards E., Freeman R. et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) vol. 124 (1) pp. 91-6.
  • Zoli M., lervese T., Merkel C., et al. Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. J Hepatol 1993; 17: 56-61.
Еще
Статья
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp